MedPath

Comparison of the effect of Plantago Syrup and Mefenamic Acid Capsule Hypermernorrhea

Not Applicable
Recruiting
Conditions
Hymenorrhea.
Excessive and frequent menstruation with regular cycle
Registration Number
IRCT2017061634576N1
Lead Sponsor
Deputy of Research and Technology of Mashhad University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Female
Target Recruitment
68
Inclusion Criteria

Criteria for entering the study of outpatients between the ages of 36-45 years with a complaint of hypernorrhoea that have negative pregnancy tests and not being breast-fed;The patient has no desire for hormonal treatment (ocp);Genic examination is normal;Pap smear sample of the patient is healthy;At the same time as hormonal treatments,Not use to other Herbal remedies and herbs; A month before entering in to the study,Doesn't use any drug to heal much hemorrhage;Use non-hormonal prevention;Hb is between 11 and 14;A patient with diabetes,Does not have uncontrolled blood pressure, congestive heart disease, and blood dislocations;The patient has no history of chronic diseases such as lupus and thyroid problems;The patient does not have a history of uterine malformations, ovaries, or other malignancies;Patient does not have hyperlichotheneemia ;Does not have IUD;The BMI is between 18/5 and 30;No fibroma.Exit criteria for patients who get pregnant during the study;Patients who use hormonal drugs during the study;Patients with possible side effects;Patients who require other interventions and have surgery;Patients who decide to leave the study with a personal request;The bleeding during the study is so severe that it requires emergency procedures.

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Severity and duration of menstrual bleeding. Timepoint: Beginning of the study and after three periods. Method of measurement: PBAC chart.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath